| Nanotechnology in agri-food production: an overview BS Sekhon Nanotechnology, science and applications 7, 31, 2014 | 539 | 2014 |
| Food nanotechnology–an overview BS Sekhon Nanotechnology, science and applications 3, 1, 2010 | 401 | 2010 |
| Ionic liquids as active pharmaceutical ingredients R Ferraz, LC Branco, C Prudencio, JP Noronha, Ž Petrovski ChemMedChem 6 (6), 975-985, 2011 | 279 | 2011 |
| An overview of advances in the standardization of herbal drugs N Choudhary, BS Sekhon Journal of Pharmaceutical Education and Research 2 (2), 55, 2011 | 189 | 2011 |
| Pharmaceutical co-crystals-a review BS Sekhon Universidad de Granada, Facultad de Farmacia, 2009 | 162 | 2009 |
| Matrix metalloproteinases–an overview BS Sekhon Research and Reports in Biology 1, 1-20, 2010 | 124 | 2010 |
| Prebiotics, probiotics and synbiotics: an overview BS Sekhon, S Jairath Journal of pharmaceutical education and research 1 (2), 13, 2010 | 117 | 2010 |
| Chiral pesticides BS Sekhon Journal of Pesticide Science 34 (1), 1-12, 2009 | 115 | 2009 |
| Biosimilars: an overview BS Sekhon, V Saluja Biosimilars 1, 1-11, 2011 | 112 | 2011 |
| Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases A Singh Grewal, S Bhardwaj, D Pandita, V Lather, B Singh Sekhon Mini reviews in medicinal chemistry 16 (2), 120-162, 2016 | 110 | 2016 |
| Reactive oxygen species and antioxidants in plants: an overview V Pandhair, BS Sekhon Journal of plant Biochemistry and Biotechnology 15 (2), 71-78, 2006 | 97 | 2006 |
| Inorganic nanomedicine—part 2 BS Sekhon, SR Kamboj Nanomedicine: Nanotechnology, Biology and Medicine 6 (5), 612-618, 2010 | 94 | 2010 |
| Enantioseparation of chiral drugs—an overview BS Sekhon Int J Pharm Technol Res 2, 1584-1594, 2010 | 89 | 2010 |
| Inorganic nanomedicine—part 1 BS Sekhon, SR Kamboj Nanomedicine: Nanotechnology, Biology and Medicine 6 (4), 516-522, 2010 | 69 | 2010 |
| Supercritical fluid technology: an overview of pharmaceutical applications BS Sekhon International Journal of PharmTech Research 2 (1), 810-826, 2010 | 68 | 2010 |
| Gemini (dimeric) surfactants BS Sekhon Resonance 9 (3), 42-49, 2004 | 59 | 2004 |
| Enhanced biosurfactant production through cloning of three genes and role of esterase in biosurfactant release KK Sekhon, S Khanna, SS Cameotra Microbial cell factories 10 (1), 49, 2011 | 58 | 2011 |
| Surfactants: pharmaceutical and medicinal aspects BS Sekhon | 57 | 2014 |
| Drug-drug co-crystals BS Sekhon DARU Journal of Pharmaceutical Sciences 20 (1), 45, 2012 | 55 | 2012 |
| Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus A Singh Grewal, B Singh Sekhon, V Lather Mini Reviews in Medicinal Chemistry 14 (7), 585-602, 2014 | 50 | 2014 |
Vikrant SalujaAssociate Professor, Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, LudhianaVerified email at pcte.edu.in
